2023 annual financial data
Ovid Therapeutics 2023 Net margin
Direct answer
Net margin was -13,351.79%.
Operating income was -59.28M USD and net income was -52.34M USD.
Operating cash flow was -45.78M USD.
Get free Ovid Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 392,000 USD
- Operating income
- -59.28M USD
- Net income
- -52.34M USD
- Operating cash flow
- -45.78M USD